Effect of outdoor air pollution on chronic thromboembolic pulmonary hypertension (CTEPH)

K. Swinnen (Leuven, Belgium), R. Quarck (Leuven, Belgium), E. Bijnens (Diepenbeek, Belgium), L. Casas (Leuven, Belgium), M. Delcroix (Leuven, Belgium), C. Belge (Leuven, Belgium)

Source: International Congress 2019 – Chronic thromboembolic pulmonary hypertension
Session: Chronic thromboembolic pulmonary hypertension
Session type: Oral Presentation
Number: 5166
Disease area: Pulmonary vascular diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Swinnen (Leuven, Belgium), R. Quarck (Leuven, Belgium), E. Bijnens (Diepenbeek, Belgium), L. Casas (Leuven, Belgium), M. Delcroix (Leuven, Belgium), C. Belge (Leuven, Belgium). Effect of outdoor air pollution on chronic thromboembolic pulmonary hypertension (CTEPH). 5166

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Residential air pollution increases the risk for persistent pulmonary hypertension after pulmonary endarterectomy
Source: Eur Respir J, 57 (5) 2002680; 10.1183/13993003.02680-2020
Year: 2021



Could pulmonary thromboembolism be associated with air pollution ?
Source: Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism
Year: 2020


Urban air pollution and chronic obstructive pulmonary disease: a review
Source: Eur Respir J 2001; 17: 1024-1033
Year: 2001



Effects of urban ozone pollution on hospitalizations for exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2015 – Indoor air and ambient pollution
Year: 2015

Acute exacerbation of idiopathic pulmonary fibrosis associated with air pollution exposure
Source: Eur Respir J 2014; 43: 1124-1131
Year: 2014



Prevalence of chronic thromboembolic pulmonary hypertension (CTEPH) in patients after pulmonary embolism
Source: International Congress 2018 – Clinical aspects of pulmonary hypertension
Year: 2018

Effect of riociguat on haemodynamic parameters and exercise capacity in patients with chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH)
Source: Annual Congress 2009 - Clinical management of pulmonary arterial hypertension
Year: 2009


Exhaled breath olfactory signature of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension
Year: 2020

A crossroads between the heart and lungs: air pollution and pulmonary hypertension
Source: Eur Respir J, 53 (5) 1900654; 10.1183/13993003.00654-2019
Year: 2019



Effect of air pollution on severe asthma and COPD
Source: International Congress 2017 – Effects of air pollution on asthma and COPD
Year: 2017


Chronic thromboembolic pulmonary hypertension (CTEPH) and beyond
Source: Annual Congress 2011 - Ceremony for Pulmonary Arterial Hypertension Award (supported by Actelion) followed by Pulmonary Hypertension in the Clinic Grand Round - an interactive session
Year: 2011


Association between exposure to air pollution and mortality in patients with idiopathic pulmonary fibrosis
Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia
Year: 2019

Relationship between comorbidities and quality of life perceived by patients diagnosed with pulmonary hypertension: Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH)
Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension
Year: 2019

The impact of airborne occupational exposure in chronic obstructive pulmonary disease
Source: Annual Congress 2010 - The impact of airborne occupational exposure in COPD
Year: 2010

Involvement of the pulmonary micro-vasculature in chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012


Prevalence of chronic thromboembolic pulmonary hypertension 2 years after pulmonary embolism
Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease
Year: 2008


Comparison of activities of daily living in patients with chronic thromboembolic pulmonary hypertension (CTEPH) and idiopathic pulmonary arterial hypertension (IPAH)
Source: International Congress 2016 – Best abstracts in exercise capacity and testing in chronic lung diseases
Year: 2016


Pulmonary hypertension frequency in patients with chronic obstructive pulmonary disease exposed to biomass or tobacco smoke
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH
Year: 2012


Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Eur Respir J, 53 (6) 1802004; 10.1183/13993003.02004-2018
Year: 2019



Are we screening survivors of acute pulmonary embolism (PE) for chronic thromboembolic pulmonary hypertension (CTEPH)?
Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism
Year: 2011